-The Times of India A year after the UPA presented a white paper on black money in Parliament, spelling out strategy to curb generation of illicit money and preventing its offshore flight, one of the most potent weapons created to tackle the menace and bring offenders to book - theincome tax department's Directorate of Criminal Investigation (DCI) - stands dismantled and powerless. The last search-and-survey operation, better known as I-T raids,...

-The Indian Express West Bengal is not new to chit fund scams. What is unique to the Saradha Group scandal is how it targeted the poorest and the most marginalised, leaving them on the verge of devastation. From 17-year-old agents who raised money from depositors to 50-year-old widows who invested money, the Saradha Group didn't discriminate in roping them in. Since the house of cards started collapsing, two agents and two...

-The Hindu     Enhancing the basket of contraceptive choices can reduce maternal mortality rate, says a family planning review Family planning has made a silent comeback in the national discourses. This time, focussing more on concomitant improvement in the health of the people rather than limiting the number of children. India had changed its strategy on family planning in 2010 with the other developing countries from that of merely reducing population to that of...

-Tehelka With 65 percent of the population below the age of 35, India boasts of an unparalleled generational dividend, but are we turning this potential into a disaster? Avalok Langer spots a ticking time bomb Nutrition & Health* 40% of children in India are malnourished 43% of children in the age group of 12-23 months receive full immunisation 48%+ of children are underweight 50%+ of all deaths under age 5 are related to malnutrition 45% of children...

-The Times of India Big pharma may be crying hoarse over India's "weak'' intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country. That's not all. The contribution of patented drugs in the Rs 72,000-crore pharma retail market is not even 1%, indicating that multinationals have been traditionally slow and have a poor track record in introducing...